{"id":84279,"date":"2025-11-12T11:07:46","date_gmt":"2025-11-12T19:07:46","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2025\/11\/12\/vance-rfk-and-other-top-trump-admin-officials-attend-maha-summit-featuring-psychedelics-session\/"},"modified":"2025-11-12T19:50:47","modified_gmt":"2025-11-13T03:50:47","slug":"vance-rfk-and-other-top-trump-admin-officials-attend-maha-summit-featuring-psychedelics-session","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2025\/11\/12\/vance-rfk-and-other-top-trump-admin-officials-attend-maha-summit-featuring-psychedelics-session\/","title":{"rendered":"Vance, RFK And Other Top Trump Admin Officials Attend MAHA Summit Featuring Psychedelics Session"},"content":{"rendered":"<\/p>\n

Vice President JD Vance, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Food and Drug Administration (FDA) Commissioner Marty Makary and other top Trump administration officials are attending a \u201cMake America Healthy Again\u201d summit that features a session on the therapeutic potential of psychedelics.<\/p>\n

Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services (CMS), and Katie Miller, wife of President Donald Trump\u2019s adviser Stephen Miller, are also among those who will be in attendance at Wednesday\u2019s event, which is meant to broadly showcase the MAHA agenda and areas of innovation in public health.<\/p>\n

Whether any of the high-profile attendees plan to go to the psychedelics session is uncertain, but the fact that the issue is receiving attention at the Trump-aligned summit is notable.<\/p>\n

German investor Christian Angermayer, founder of the psychedelics company AtaiBeckley, will lead the fireside chat, Politico reported<\/a>. The biopharmaceutical corporation has been working to develop a 5-MeO-DMT therapeutic for the treatment of severe depression.<\/p>\n

The session is titled, \u201cPsychedelic Medicine: The Next Frontier In Mental Health.\u201d<\/p>\n

\u201cToday is an important milestone,\u201d Tony Lyons, president of MAHA Action, said of the overall event in a press release. \u201cIt\u2019s the culmination of a movement that was 40 years in the making \u2013 a movement that will usher in a generation of healthier children and an era of incredible innovation geared toward prevention rather than treatment.\u201d<\/p>\n

\n
\n

MAHA™ Summit Unites Leaders Across Government, Industry, and Innovation to Advance America\u2019s Health Revolution pic.twitter.com\/BHgPtkUUof<\/a><\/p>\n

\u2014 MAHA Action (@MAHA_Action) November 12, 2025<\/a><\/p>\n<\/blockquote>\n

<\/div>\n

The vice president, for his part, previously expressed interest in psychedelics therapy<\/a>, telling podcaster Joe Rogan last year that he\u2019s \u201cfascinated\u201d by the topic and that he\u2019d like to learn more about potential regulatory pathways to provide medical access to substances like MDMA and psilocybin.<\/p>\n

Kennedy campaigned on legalizing and taxing psychedelics to support mental health treatment programs back when he was running for the 2024 Democratic presidential nomination. And he\u2019s continued to be involved in conversations about advancing the issue since joining the Trump administration has head of HHS.<\/p>\n

In June, Kennedy said his agency is\u00a0\u201cabsolutely committed\u201d to expanding research on the benefits of psychedelic therapy<\/a>\u00a0and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans \u201cwithin 12 months.\u201d<\/p>\n

FDA\u2019s Makary also said in May that exploring the therapeutic potential of psychedelics such as psilocybin and ibogaine is a \u201ctop priority\u201d<\/a> for the Trump administration, especially when it comes to helping military veterans grapple with trauma from being sent to fight \u201cunnecessary wars.\u201d<\/p>\n

Meanwhile, a U.S. Department of Veterans Affairs (VA) official recently said the federal government needs to \u201cgear up\u201d to provide psychedelic medicines<\/a> to veterans and ensure that therapists are equipped to facilitate the novel therapy.<\/p>\n

Former U.S. House Speaker Newt Gingrich (R-GA) over the summer extolled the therapeutic promise of ibogaine on an episode of his podcast<\/a>, drawing attention to a Stanford University study that found the psychedelic showed potential to treat PTSD, anxiety and depression in military veterans with traumatic brain injury.<\/p>\n

The message around the therapeutic potential of psychedelics has been getting out in a number of ways, including in prominent conservative media circles and within the Trump administration.<\/p>\n

For example, a Navy SEAL veteran credited with killing Osama Bin Laden said during a Fox News interview that psychedelic therapy has helped him process the trauma he experienced during his time in the military,\u00a0stressing that \u201cit works\u201d and should be an available treatment option<\/a>.<\/p>\n

That interview came days after the U.S. House of Representatives included an amendment to a spending bill from Reps. Lou Correa (D-CA) and Jack Bergman (R-MI) that would encourage VA to support research into the benefits of psychedelics in treating medical conditions<\/a>\u00a0commonly affecting military veterans.<\/p>\n

VA Secretary Doug Collins also disclosed in April that he had an \u201ceye-opening\u201d talk with Kennedy\u00a0about the therapeutic potential of psychedelic medicine<\/a>. And he said he\u2019s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access.<\/p>\n

Collins also\u00a0recently visited a facility conducting research on psychedelics<\/a>, and he reiterated that it\u2019s his \u201cpromise\u201d to advance research into the therapeutic potential of the substances\u2014even if that might take certain policy changes within the department and with congressional support.<\/p>\n

The secretary\u2019s visit to the psychedelics research center came about a month after the VA secretary met with a military veteran who\u2019s become an advocate for psilocybin access to\u00a0discuss the therapeutic potential of psychedelic medicine for the veteran community<\/a>.<\/p>\n

Collins also\u00a0briefly raised the issue in a Cabinet meeting with the president<\/a>\u00a0in April.<\/p>\n

Correa and Bergman\u2014co-chairs of the Congressional Psychedelic Advancing Therapies (PATH) Caucus\u2014introduced a bill in April to provide $30 million in funding annually\u00a0to establish psychedelics-focused \u201ccenters for excellence\u201d at VA facilities<\/a>, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine.<\/p>\n

Bergman has also\u00a0expressed optimism about the prospects of advancing psychedelics reform under Trump<\/a>, arguing that the administration\u2019s efforts to cut spending and the federal workforce will give agencies \u201cspines\u201d to tackle such complex issues.<\/p>\n

Kennedy, for his part, also said in April that\u00a0he had a \u201cwonderful experience\u201d with LSD at 15 years old<\/a>, which he took because he thought he\u2019d be able to see dinosaurs, as portrayed in a comic book he was a fan of.<\/p>\n

Last October, Kennedy specifically criticized FDA under the prior administration over the agency\u2019s \u201csuppression of psychedelics\u201d and a laundry list of other issues that he said amounted to a \u201cwar on public health\u201d that would end under the Trump administration.<\/p>\n

In December, VA separately announced that it\u2019s providing $1.5 million in funding to\u00a0study the efficacy of MDMA-assisted therapy for veterans<\/a>\u00a0with PTSD and alcohol use disorder (AUD).<\/p>\n

In January, former VA Under Secretary for Health Shereef Elnahal said that it was \u201cvery encouraging\u201d that Trump\u2019s pick to have Kennedy lead HHS has supported psychedelics reform. And he\u00a0hoped to work with him on the issue if he stayed on<\/a>\u00a0for the next administration, but that didn\u2019t pan out.<\/p>\n

Image courtesy of CostaPPR<\/a>.<\/em><\/p>\n

The post Vance, RFK And Other Top Trump Admin Officials Attend MAHA Summit Featuring Psychedelics Session<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n


\n
\nRead More: Vance, RFK And Other Top Trump Admin Officials Attend MAHA Summit Featuring Psychedelics Session<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Vice President JD Vance, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Food and Drug Administration (FDA) Commissioner Marty Makary and other top Trump administration officials are attending a \u201cMake America Healthy Again\u201d summit that features a session on the therapeutic potential of psychedelics. Mehmet Oz, the administratorContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":458,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[18,81],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/84279"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=84279"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/84279\/revisions"}],"predecessor-version":[{"id":84280,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/84279\/revisions\/84280"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=84279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=84279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=84279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}